Page 81 - Predicting survival in patients with spinal bone metastasesL
P. 81
REFERENCES
1. Bollen L, De Ruiter GC, Pondaag W. Risk factors for survival in 106 surgically treated patients with symptomatic spinal epidural metastasis. Eur Spine J. 2013;22:1408-1416.
2. Leithner A, Radl R, Gruber G, et al. Predictive value of seven preoperative prognostic scoring systems for spinal metastases. Eur. Spine J. 2008;17(11):1488-95.
3. Wibmer C, Leithner A, Hofmann G, et al. Survival analysis of 254 patients after manifestation of spinal metastases - evaluation of seven preoperative scoring systems. Spine. 2011;36(23):1977-86.
4. Wang M, Bünger CE, Li H, et al. Predictive value of Tokuhashi scoring systems in spinal metastases, focusing on various primary tumor groups: evaluation of 448 patients in the Aarhus spinal metastases database. Spine. 2012;37(7):573-82.
5. Tomita K, Kawahara N, Kobayashi T, et al. Surgical strategy for spinal metastases. Spine. 2001;26(3):298- 306.
6. Tokuhashi Y, Matsuzaki H, Oda H, et al. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine. 2005;30(19):2186-91.
7. Linden YM, Dijkstra PDS, Vonk E, et al. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer. 2005;103(2):320-8.
8. Bauer HC, Wedin R. Survival after surgery for spinal and extremity metastases: Prognostication in 241 patients. Acta Orthop Scand. 1995;66(2)143-6.
9. Bollen L, van der Linden YM, Pondaag W, et al. Prognostic factors associated with survival in patients
with symptomatic spinal bone metastases: a retrospective cohort study of 1 043 patients. Neuro oncol. 2014;16(7):991-998. V
10. Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000; 406(6797): 747–52.
11. Sørlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001;98(19):10869-74.
12. Dawood S, Hu R, Homes M, et al. Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study. Breast Cancer Res. 2011;126(1):185-92.
13. Vallejos C, Gómez H, Cruz W. et al. Breast cancer classification according to immunohistochemistry markers: subtypes and association with clinicopathologic variables in a Peruvian hospital database. Clin. Breast Cancer. 2010;10(4):294-300.
14. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996; 17(4): 343–6.
15. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996; 15(4): 361-87.
16. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492-502.
17. Fan C, Oh DS, Wessels L, et al. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med. 2006;355(6):560-9.
18. Sciubba DM, Gokaslan ZL, Suk I, et al. Positive and negative prognostic variables for patients undergoing spine surgery for metastatic breast disease. Eur Spine J. 2007;16(10):1659-67.
19. Rades D, Douglas S, Schild SE. A validated survival score for breast cancer patietns with metastatic spinal cord compression. Strahlenther Onkol. 2013;189(1):41-6.
BREAST CANCER
79
